<DOC>
	<DOCNO>NCT02082496</DOCNO>
	<brief_summary>The obesity epidemic attributable dietary behavioral trend act person 's genetic makeup determine body mass susceptibility obesity-related disease . Common form obesity strong hereditary component many genetic pathway contribute obesity already ben identify . Glucagon-like peptide ( GLP ) -1 incretin hormone potentiate glucose-stimulated insulin secretion . However , GLP-1 also act appetite-inhibiting hormone affect appetite center hypothalamus . Today , GLP-1 agonists available treatment type 2 diabetes , treatment potential obesity area active research . The aim study explore appetite inhibiting effect GLP-1 intact people diagnose obesity cause genetic disorder investigate physiological role GLP-1 food intake appetite regulation group .</brief_summary>
	<brief_title>GLP-1 Response Effect Individuals With Obesity Causing Genetic Mutations</brief_title>
	<detailed_description>- Exploration physiological role GLP-1 concern food intake appetite regulation obese adult diagnose obesity relate genetic disorder . - Assessment effect GLP-1 body composition , bone mineral density , energy expenditure , cardiac function , glucose tolerance , insulin sensitivity , lipid concentration neuroendocrine function . - Assessment impact leptin induce adaptive thermogenesis response weight reduce study participant . - Investigating alteration composition gut bacteria well subjective rating satiety hunger supplement GLP-1 .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>BMI 28 ( kg/m2 ) age 1865 year otherwise healthy pregnancy breastfeed Type 2 Diabetes suffer severe medical condition Recruitment study finish November 2015</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Obesity Genetics</keyword>
	<keyword>GLP-1</keyword>
	<keyword>GLP-1 Receptor Agonists</keyword>
</DOC>